132 related articles for article (PubMed ID: 7684595)
1. Long term results of treatment in patients with extragonadal germ cell tumours.
Gutierrez Delgado F; Tjulandin SA; Garin AM
Eur J Cancer; 1993; 29A(7):1002-5. PubMed ID: 7684595
[TBL] [Abstract][Full Text] [Related]
2. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Ann Oncol; 2002 Jul; 13(7):1017-28. PubMed ID: 12176779
[TBL] [Abstract][Full Text] [Related]
3. Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.
Hsu YJ; Pai L; Chen YC; Ho CL; Kao WY; Chao TY
Cancer; 2002 Aug; 95(4):766-74. PubMed ID: 12209720
[TBL] [Abstract][Full Text] [Related]
4. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
[TBL] [Abstract][Full Text] [Related]
5. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
[TBL] [Abstract][Full Text] [Related]
6. Therapy of extragonadal germ-cell tumors.
Daugaard G; Rørth M; Hansen HH
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):895-9. PubMed ID: 6192996
[TBL] [Abstract][Full Text] [Related]
7. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
8. Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
Bokemeyer C; Hartmann JT; Fossa SD; Droz JP; Schmol HJ; Horwich A; Gerl A; Beyer J; Pont J; Kanz L; Nichols CR; Einhorn L
APMIS; 2003 Jan; 111(1):49-59; discussion 59-63. PubMed ID: 12752235
[TBL] [Abstract][Full Text] [Related]
9. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience.
De Giorgi U; Demirer T; Wandt H; Taverna C; Siegert W; Bornhauser M; Kozak T; Papiani G; Ballardini M; Rosti G;
Ann Oncol; 2005 Jan; 16(1):146-51. PubMed ID: 15598952
[TBL] [Abstract][Full Text] [Related]
10. Multimodality treatment of malignant germ cell tumours of the mediastinum.
Giaccone G
Eur J Cancer; 1991; 27(3):273-7. PubMed ID: 1851024
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.
Makino T; Konaka H; Namiki M
Anticancer Res; 2016 Jan; 36(1):313-7. PubMed ID: 26722059
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of extragonadal germ cell tumors.
Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
14. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Bokemeyer C; Nichols CR; Droz JP; Schmoll HJ; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Hartmann JT
J Clin Oncol; 2002 Apr; 20(7):1864-73. PubMed ID: 11919246
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes in patients with primary mediastinal non-seminomatous germ cell tumours and elevated post-chemotherapy serum tumour markers.
De Latour B; Fadel E; Mercier O; Mussot S; Fabre D; Fizazi K; Dartevelle P
Eur J Cardiothorac Surg; 2012 Jul; 42(1):66-71; discussion 71. PubMed ID: 22290909
[TBL] [Abstract][Full Text] [Related]
18. Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest Oncology Group study.
Bukowski RM; Wolf M; Kulander BG; Montie J; Crawford ED; Blumenstein B
Cancer; 1993 Apr; 71(8):2631-8. PubMed ID: 7680950
[TBL] [Abstract][Full Text] [Related]
19. Extragonadal germ cell tumors. A 14-year Toronto experience.
Goss PE; Schwertfeger L; Blackstein ME; Iscoe NA; Ginsberg RJ; Simpson WJ; Jones DP; Shepherd FA
Cancer; 1994 Apr; 73(7):1971-9. PubMed ID: 8137224
[TBL] [Abstract][Full Text] [Related]
20. Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients.
McLeod DG; Taylor HG; Skoog SJ; Knight RD; Dawson NA; Waxman JA
Cancer; 1988 Mar; 61(6):1187-91. PubMed ID: 2449276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]